Cesarean Delivery Completed Phase 4 Trials for Ketamine (DB01221)

IndicationStatusPhase
DBCOND0036001 (Cesarean Delivery)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03336541Low-dose Ketamine and Postpartum Depression in Parturients With Prenatal DepressionPrevention